Literature DB >> 29409577

Proper Antibiotic Use in a Home-Based Primary Care Population Treated for Urinary Tract Infections.

Megan E Gee, James Ford, Erin L Conway, Michael C Ott, John A Sellick, Kari A Mergenhagen.   

Abstract

OBJECTIVE: To evaluate the trends associated with diagnosis and treatment of urinary tract infections (UTI) in a home-based primary care population of Veterans Health System patients from 2006 to 2015.
DESIGN: Retrospective cohort study.
SETTING: Veterans Healthcare System. PARTICIPANTS: Home-based primary care patients treated for UTI from 2006 to 2015.
INTERVENTIONS: None. MAIN OUTCOME MEASURE: Appropriate therapy was determined based on the McGeer criteria. Multivariate logistic regression was used to determine factors leading to appropriate UTI treatment.
RESULTS: Of 366 available patients, 68 (18.6%) were tested for a UTI. Appropriate therapy occurred in 26% of patients. Allergy to any antibiotic increased the odds of appropriate treatment (odds ratio [OR] = 5.6, 95% confidence interval [CI] 1.5-23.2). Flank pain and increased urinary frequency also increased the likelihood of being treated appropriately (OR = 25.9, 95% CI 2.9-584.0 and OR = 4.49, 95% CI 0.99-21.2, respectively).
CONCLUSION: Antibiotics were overused for treating UTIs in the homebound population. Patients with flank pain, increased urinary frequency, and antibiotic allergy were more likely to receive appropriate treatment. Pharmacists, therefore, have a viable opportunity to increase appropriate antibiotic prescribing in the home-based primary care population.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29409577     DOI: 10.4140/TCP.n.2018.105

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  1 in total

1.  National Cohort Study of Homebound Persons Living With Dementia: Antibiotic Prescribing Trends and Opportunities for Antibiotic Stewardship.

Authors:  Rupak Datta; Terri Fried; John R O'Leary; Andrew R Zullo; Heather Allore; Ling Han; Manisha Juthani-Mehta; Andrew Cohen
Journal:  Open Forum Infect Dis       Date:  2022-09-03       Impact factor: 4.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.